A Study to Assess the Safety and Efficacy of Prograf and MR4 in Kidney Transplantation Patients

This study has been completed.

Sponsor:

Collaborator:

Astellas Pharma Korea, Inc.

Information provided by:

Astellas Pharma Inc

ClinicalTrials.gov Identifier:

NCT00720265

First received: July 18, 2008

Last updated: NA

Last verified: July 2008

History: No changes posted

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	March 2008
Primary Completion Date:	March 2008 (Final data collection date for primary outcome measure)